Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (261-270 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1987
The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levelsP Lissoni, A Bastone, R Sala, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1995
Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II studyP Lissoni, L Vigorè, R Rescaldani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinomaR Aldeghi, P Lissoni, S Barni, et al.
The International Journal of Biological Markers|July 17, 2004
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsP Lissoni, F Brivio, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1994
A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptorsP Lissoni, F Brivio, L Fumagalli, et al.
Chronobiologia|October 1, 1986
Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activityP Lissoni, O Marelli, R Mauri, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1995
Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumorsP Lissoni, F Rovelli, E Tisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatoninP Lissoni, S Pittalis, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
Tumor necrosis factor in solid tumors: increased blood levels in the metastatic diseaseA Ardizzoia, P Lissoni, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1993
Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alphaP Lissoni, A Ardizzoia, M S Perego, et al.
Pageof 29

Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Cancer & Clinical Oncology|July 1, 1987
The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levelsP Lissoni, A Bastone, R Sala, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1995
Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II studyP Lissoni, L Vigorè, R Rescaldani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinomaR Aldeghi, P Lissoni, S Barni, et al.
The International Journal of Biological Markers|July 17, 2004
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsP Lissoni, F Brivio, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1994
A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptorsP Lissoni, F Brivio, L Fumagalli, et al.
Chronobiologia|October 1, 1986
Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activityP Lissoni, O Marelli, R Mauri, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1995
Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumorsP Lissoni, F Rovelli, E Tisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatoninP Lissoni, S Pittalis, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
Tumor necrosis factor in solid tumors: increased blood levels in the metastatic diseaseA Ardizzoia, P Lissoni, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1993
Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alphaP Lissoni, A Ardizzoia, M S Perego, et al.
Pageof 29